Live Breaking News & Updates on Novome Bio

Stay updated with breaking news from Novome bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

4 microbiome companies turning gut bacteria into tomorrow's drugs


This story is available exclusively to Insider subscribers.
Become an Insider and start reading now.
A top healthcare VC predicted microbiome drugs would rebound in 2021 as part of Business Insider s year-end roundup of healthcare predictions.
Though the biotech industry s infatuation with the promise of the bacteria in our gut dates back years, research failures and the 2019 uBiome scandal previously chilled investors interests.
More established microbiome companies have continued the search to prove the microbiome can bear fruit for patients and investors alike.
Seres Therapeutics, currently valued at $2.4 billion, is the space s clear frontrunner, having announced success last August in a late-stage study for one of its microbiome drug candidates. ....

United Kingdom , United States , Blake Wise , Novome Bio , Racquel Bracken , Assembly Biosciences , Armata Pharmaceuticals , Federation Bio , Business Insider , Massachusetts Based Seres Therapeutics , Kaleido Biosciences , Finch Therapeutics , Bay Area Based , Gut Microbes , Drug Development , Drug Approval , Bi Prime , Patricia Kelly Yeo , Andrew Dunn , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , பிளேக் பாண்டித்தியம் , சட்டசபை உயிர் அறிவியல் , அர்மாட்டா மருந்துகள் , கூட்டமைப்பு உயிர் , வணிக உள் ,